Purpose: To investigate the clinical outcomes of a dedicated hybrid oblique nitinol stent that has been specifically designed to treat common iliac vein compression. Methods: The Bern Venous Stent Registry database was interrogated to identify all patients who had at least 6-month follow-up after treatment with the sinus-Obliquus hybrid stent for common iliac vein compression. The search identified 24 patients (mean age 39±18 years; 20 women) who matched the search criteria. Ten patients had postthrombotic syndrome (PTS), another 10 patients had acute iliofemoral thrombosis after catheter-directed therapy, and 4 patients had nonthrombotic iliac vein compression. Primary treatment success was defined as antegrade flow and stenosis <30% on venography and evidence of a spontaneous Doppler signal in the treated segment. Stent patency was assessed using duplex ultrasound. Clinical outcomes were evaluated using a clinical symptom score (Villalta) and the revised venous clinical severity score (rVCSS) at 3, 6, and 12 months in follow-up. Results: Primary treatment success was achieved in all patients. Mean follow-up was 10±3 months. Primary patency estimates by Kaplan-Meier analysis were 92% at 6 months [95% confidence interval (CI) 71% to 98%] and 83% (95% CI 54% to 95%) at 10 months. Three symptomatic patients underwent reintervention for early and late stent thromboses and the third for in-stent restenosis, resulting in secondary patency of 100%. Overall, all patients had clinical improvement at the latest follow-up; 50% reported complete resolution of symptoms. In patients with PTS, the Villalta score decreased by 6±6 points (p=0.02) and the rVCSS score by 3±1 points (p=0.05). Among deep vein thrombosis patients, none developed PTS. Conclusion: In patients with common iliac vein compression, the oblique hybrid nitinol stent appears to provide excellent early patency and clinical outcomes.
KahnSRGinsbergJS.The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev. 2002;16:155–165.
2.
KahnSRComerotaAJCushmanM. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130:1636–1661.
3.
KahnSRPartschHVedanthamS. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879–883.
4.
BaldwinMJMooreHMRudarakanchanaN. Post-thrombotic syndrome: a clinical review. J Thromb Haemost. 2013;11:795–805.
5.
TickLWKramerMHRosendaalFR. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost. 2008;6:2075–2081.
6.
EndenTHaigYKlowNE. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31–38.
7.
NazirSAGaneshanANazirS. Endovascular treatment options in the management of lower limb deep venous thrombosis. Cardiovasc Intervent Radiol. 2009;32:861–876.
8.
CakirVGulcuAAkayE. Use of percutaneous aspiration thrombectomy vs. anticoagulation therapy to treat acute iliofemoral venous thrombosis: 1-year follow-up results of a randomised, clinical trial. Cardiovasc Intervent Radiol. 2014;37:969–976.
9.
RajuSOwenSJrNeglenP.The clinical impact of iliac venous stents in the management of chronic venous insufficiency. J Vasc Surg. 2002;35:8–15.
10.
YeKLuXJiangM. Technical details and clinical outcomes of transpopliteal venous stent placement for postthrombotic chronic total occlusion of the iliofemoral vein. J Vasc Interv Radiol. 2014;25:925–932.
11.
BozkayaHCinarCErtugayS. Endovascular treatment of iliac vein compression (May-Thurner) syndrome: angioplasty and stenting with or without manual aspiration thrombectomy and catheter-directed thrombolysis. Ann Vasc Dis. 2015;8:21–28.
12.
YinMWangWHuangX. Endovascular recanalization of chronically occluded native arteries after failed bypass surgery in patients with critical ischemia. Cardiovasc Intervent Radiol. 2015;38:1468–1476.
13.
PatelNHStookeyKRKetchamDB. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interv Radiol. 2000;11:1297–1302.
14.
MussaFFPedenEKZhouW. Iliac vein stenting for chronic venous insufficiency. Tex Heart Inst J. 2007;34:60–66.
15.
WohlgemuthWAWeberHLoeprechtH. PTA and stenting of benign venous stenoses in the pelvis: long-term results. Cardiovasc Intervent Radiol. 2000;23:9–16.
de WolfMAde GraafRKurstjensRL. Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg. 2015;50:518–526.
19.
SariciISYanarFAgcaogluO. Our early experience with iliofemoral vein stenting in patients with post-thrombotic syndrome. Phlebology. 2014;29:298–303.
20.
JeonUBChungJWJaeHJ. May-Thurner syndrome complicated by acute iliofemoral vein thrombosis: helical CT venography for evaluation of long-term stent patency and changes in the iliac vein. AJR Am J Roentgenol. 2010;195:751–757.
RajuSNeglenP.High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: a permissive role in pathogenicity. J Vasc Surg. 2006;44:136–143.
23.
ParkJYAhnJHJeonYS. Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome. Phlebology. 2014;29:461–470.
EngelbergerRPSpirkDWillenbergT. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv. 2015;8:e002027.
26.
EngelbergerRPFahrniJWillenbergT. Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis. Thromb Haemost. 2014;111:1153–1160.
27.
VasquezMARabeEMcLaffertyRB. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg. 2010;52:1387–1396.
28.
YinMShiHYeK. Clinical assessment of endovascular stenting compared with compression therapy alone in post-thrombotic patients with iliofemoral obstruction. Eur J Vasc Endovasc Surg. 2015;50:101–107.
29.
O’SullivanGJSheehanJLohanD. Iliofemoral venous stenting extending into the femoral region: initial clinical experience with the purpose-designed Zilver Vena stent. J Cardiovasc Surg (Torino). 2013;54:255–261.
30.
Wen-daWYuZYue-XinC.Stenting for chronic obstructive venous disease: a current comprehensive meta-analysis and systematic review. Phlebology. 2016;31:376–389.
31.
NeglenPHollisKCOlivierJ. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007;46:979–990.
